Chronic carbamazepine therapy does not influence mivacurium-induced neuromuscular block

British Journal of Anaesthesia

Volumn 77, Issue 4, 1996, Pages 500-502

  Spacek, A ^a   Neiger, F X ^a   Spiss, C K ^a   Kress, H G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anticonvulsants; Neuromuscular block, measurement of response; Neuromuscular block, mivacurium

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; FENTANYL; ISOFLURANE; MIVACURIUM; NITROUS OXIDE; THIOPENTAL;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELECTROMYOGRAM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; NEUROSURGERY; PREMEDICATION; PRIORITY JOURNAL; ULNAR NERVE;

EID: 0029838929     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/77.4.500     Document Type: Article

References (16)

1. Whalley DG, Ebrahim ZY. Influence of carbamazepine on the dose-response relationship of vecuronium. British Journal of Anaesthesia 1994; 72: 125-126.
2. Norman J. Resistance to vecuronium. Anaesthesia 1993; 48: 1068-1069.
3. Roth S, Ebrahim ZY. Resistance to pancuronium in patients receiving carbamazepine. Anesthesiology 1987; 66: 691-693.
4. Ornstein E, Matteo RS, Weinstein JA, Halevy JD, Young WL, Abou-Donia MM. Accelerated recovery from doxacurium-induced neuromuscular blockade in patients receiving chronic anticonvulsant therapy. Journal of Clinical Anesthesia 1991; 3: 108-111.
5. Jellish WS, Modica PA, Tempelhoff R. Accelerated recovery from pipecuronium in patients treated with anticonvulsant therapy. Journal of Clinical Anesthesia 1993; 5: 105-108.
6. Savarese JJ, Ali HH, Basta SJ, Embree PB, Scott RP, Sunder N, Weakly JN, Wasila WB, El-Sayad HA. The clinical neuromuscular pharmacology of mivacurium chloride (BW B 1090U). A short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology 1988; 68: 723-732.
7. Cook RD, Freeman JA, Lai AA, Kang Y, Stiller RL, Aggarwal S, Harrelson JC, Welch RM, Samara B. Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. British Journal of Anaesthesia 1992; 69: 580-585.
8. Jellish WS, Thalji Z, Brundidge PK, Tempelhoff R. Recovery from mivacuriuminduced neuromuscular blockade is not affected by anticonvulsant therapy. Journal of Neurosurgical Anesthesiology 1996; 8: 4-8.
9. Benzi G, Arrigoni E, Scelsi R, Marzatico F, Gorini A, Villa RF. Acetylcholine esterase sensitivity to chronic administration of diphenylhydantoin and effects on cerebral enzymatic activities related to energy metabolism. Neurochemical Research 1980; 5: 905-911.
10. Kim CS, Arnold FJ, Itani MS, Martyn JAJ. Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes. Anesthesiology 1992; 77: 500-506.
11. Ornstein E, Matteo RS, Young WL, Diaz J. Resistance to metocurine-induced neuromuscular blockade in patients receiving phenytoin. Anesthesiology 1985; 63: 294-298.
12. Alloul K, Whalley DG, Shutway F, Ebrahim Z, Varin F. Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients. Anesthesiology 1996; 84: 330-339.
13. Ornstein E, Matteo RS, Schwartz AE, Silverberg PA, Young WL, Diaz J. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium. Anesthesiology 1987; 67: 191-196.
14. Ebrahim ZY, Bulkey R, Roth S. Carbamazepine therapy and neuromuscular blockade with atracurium or vecuronium. Anesthesia and Analgesia 1988; 67: S55.
15. Spacek A, Neiger FX, Katz RL, Watkins WD, Spiss CK. No effect of chronic carbamazepine therapy on atracuriuminduced neuromuscular blockade! Anesthesia and Analgesia 1995; 80: S464.
16. Tempelhoff R, Modica PA, Jellish WS, Spitznagel EL. Resistance to atracuriuminduced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants. Anesthesia and Analgesia 1990; 71: 665-669.